A randomized comparative study assessing once versus twice a day treatment of benign prostatic hyperplasia with terazosin
We compared the efficacy of once a day administration of terazosin hydrochloride with that of twice a day administration for benign prostatic hyperplasia (BPH) patients. Forty-two patients with BPH were randomly assigned to receive a maximum dose of 2 mg terazosin either once (n = 21) or twice (n =...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 47(2001), 2 vom: 01. Feb., Seite 77-81 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
2001
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | Clinical Trial English Abstract Journal Article Multicenter Study Randomized Controlled Trial Adrenergic alpha-Antagonists Terazosin 8L5014XET7 Prazosin XM03YJ541D |